Sign Up to like & get
recommendations!
0
Published in 2021 at "Immunotherapy"
DOI: 10.2217/imt-2021-0001
Abstract: Background: Pembrolizumab is a monoclonal antibody targeting PD-1. Folliculitis secondary to pembrolizumab has rarely been reported in the treatment of malignant melanoma. Case: A 49-year-old with a history of mild lower limb folliculitis developed metastatic…
read more here.
Keywords:
follicular eruption;
induced follicular;
pembrolizumab induced;
isotretinoin ... See more keywords